Cynata Therapeutics Limited(DE:51S)
€0.140.00 (0.00%)
DE:51S
Cynata Therapeutics Limited stock forecast
€0.14
At close:0.00 (0.00%)
Cynata Therapeutics Limited (51S) Stock Forecast & Price Target
0 Followers
51S Analyst Ratings
Currently, no data available
51S Stock 12 Month Forecast
There Are No Analyst Ratings for 51S In The Last 3 Months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | €0.01→€0.01 | hold | -93.65%Downside | Upgraded | 11/11/26 | ||
| Google Biotechnology | TipRanks - Google | €0.01→€0.01 | sell | -93.65%Downside | Reiterated | 11/11/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | €0.01→€0.01 | sell | -94.11%Downside | Reiterated | 11/11/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | €0.01→€0.01 | hold | -93.20%Downside | Reiterated | 11/11/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | €0.01→€0.01 | hold | -93.65%Downside | Upgraded | 11/11/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | €0.01→€0.01 | hold | -93.65%Downside | Upgraded | 11/11/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | HoldUpgraded€0.01→€0.01 | 11/11/26 | -93.65%Downside | ||
| Google BiotechnologyTipRanks - Google | SellReiterated€0.01→€0.01 | 11/11/26 | -93.65%Downside | ||
| Anthropic BiotechnologyTipRanks - Anthropic | SellReiterated€0.01→€0.01 | 11/11/26 | -94.11%Downside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldReiterated€0.01→€0.01 | 11/11/26 | -93.20%Downside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | HoldUpgraded€0.01→€0.01 | 11/11/26 | -93.65%Downside | ||
| xAI - Grok-4.3TipRanks - xAI | HoldUpgraded€0.01→€0.01 | 11/11/26 | -93.65%Downside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
51S Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 51S has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 51S average Analyst price target in the past 3 months is ―.
51S Financial Forecast
Consensus€-0.02
51S Earnings Forecast
Next quarter’s earnings estimate for 51S is -EUR 0.02 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.02. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
Consensus€0.00
51S Sales Forecast
Next quarter’s sales forecast for 51S is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
51S Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Cynata Therapeutics Limited?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Cynata Therapeutics Limited?
To buy shares of DE:51S, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
